Sk Denmed Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -100.00%
(FY 2023)
- Profit -4.62%
(FY 2023)
- Ebitda -0.12%
(FY 2023)
- Net Worth -1.90%
(FY 2023)
- Total Assets -0.00%
(FY 2023)
About Sk Denmed
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mujeeb Khan, Satinder Singh, and Vinod Sethi serve as directors at the Company.
- CIN/LLPIN
U33116DL2014PTC265203
- Company No.
265203
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Feb 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Sk Denmed Private Limited offer?
Sk Denmed Private Limited offers a wide range of products and services, including Dentist Tools, Equipment & Supplies, Dental Equipment, Dental Instruments, Packaging & Lamination Machinery, Vacuum Packaging Machines, Autoclaves, Sterilizers & Incubators, UV Sterilizer and Lamps, Chemical Plants & Machinery, Chemical Plant, Endodontic Instruments.
Who are the key members and board of directors at Sk Denmed?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mujeeb Khan  | Director | 21-Feb-2014 | Current |
| Satinder Singh | Director | 21-Feb-2014 | Current |
| Vinod Sethi | Director | 21-Feb-2014 | Current |
Financial Performance and Corporate Structure Insights of Sk Denmed.
Sk Denmed Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a slight decrease in profitability, with a 4.62% decrease in profit. The company's net worth dipped by a decrease of 1.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sk Denmed?
Unlock access to Sk Denmed's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sk Denmed?
Unlock and access historical data on people associated with Sk Denmed, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sk Denmed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sk Denmed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
